BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9284059)

  • 1. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation.
    Kar S; Seto D; Doré S; Chabot JG; Quirion R
    Neuroscience; 1997 Oct; 80(4):1041-55. PubMed ID: 9284059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entorhinal cortex lesion induces differential responses in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in the rat hippocampal formation.
    Kar S; Baccichet A; Quirion R; Poirier J
    Neuroscience; 1993 Jul; 55(1):69-80. PubMed ID: 8350993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of neonatal kainate treatment on hippocampal insulin-like growth factor receptors.
    Doré S; Kar S; Chabot JG; Quirion R
    Neuroscience; 1999; 91(3):1035-43. PubMed ID: 10391481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA(A) receptor subunits in the rat hippocampus II: altered distribution in kainic acid-induced temporal lobe epilepsy.
    Schwarzer C; Tsunashima K; Wanzenböck C; Fuchs K; Sieghart W; Sperk G
    Neuroscience; 1997 Oct; 80(4):1001-17. PubMed ID: 9284056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats.
    Pérez J; Vezzani A; Civenni G; Tutka P; Rizzi M; Schüpbach E; Hoyer D
    Neuroscience; 1995 Apr; 65(4):1087-97. PubMed ID: 7617164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats.
    Doré S; Kar S; Rowe W; Quirion R
    Neuroscience; 1997 Oct; 80(4):1033-40. PubMed ID: 9284058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase-67-positive hippocampal interneurons undergo a permanent reduction in number following kainic acid-induced degeneration of ca3 pyramidal neurons.
    Shetty AK; Turner DA
    Exp Neurol; 2001 Jun; 169(2):276-97. PubMed ID: 11358442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy.
    Bouilleret V; Ridoux V; Depaulis A; Marescaux C; Nehlig A; Le Gal La Salle G
    Neuroscience; 1999 Mar; 89(3):717-29. PubMed ID: 10199607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy.
    Tsunashima K; Schwarzer C; Kirchmair E; Sieghart W; Sperk G
    Neuroscience; 1997 Oct; 80(4):1019-32. PubMed ID: 9284057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield.
    Magloczky Z; Freund TF
    Neuroscience; 1993 Sep; 56(2):317-35. PubMed ID: 8247263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation.
    Kar S; Seto D; Doré S; Hanisch U; Quirion R
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14054-9. PubMed ID: 9391151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats.
    Kofler N; Kirchmair E; Schwarzer C; Sperk G
    Neurosci Lett; 1997 Jul; 230(2):129-32. PubMed ID: 9259481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kainate-induced epilepsy alters protein expression of AMPA receptor subunits GluR1, GluR2 and AMPA receptor binding protein in the rat hippocampus.
    Sommer C; Roth SU; Kiessling M
    Acta Neuropathol; 2001 May; 101(5):460-8. PubMed ID: 11484817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced but fragile inhibition in the dentate gyrus in vivo in the kainic acid model of temporal lobe epilepsy: a study using current source density analysis.
    Wu K; Leung LS
    Neuroscience; 2001; 104(2):379-96. PubMed ID: 11377842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of catalytic and non-catalytic trkB messenger RNAs in the rat hippocampus following seizures induced by systemic administration of kainate.
    Dugich-Djordjevic MM; Ohsawa F; Okazaki T; Mori N; Day JR; Beck KD; Hefti F
    Neuroscience; 1995 Jun; 66(4):861-77. PubMed ID: 7651614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield.
    Maglóczky Z; Freund TF
    Neuroscience; 1995 Jun; 66(4):847-60. PubMed ID: 7651613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital.
    Sutula T; Cavazos J; Golarai G
    J Neurosci; 1992 Nov; 12(11):4173-87. PubMed ID: 1432095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons.
    Doré S; Kar S; Quirion R
    Neuroscience; 1997 May; 78(2):373-83. PubMed ID: 9145794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain.
    Kar S; Chabot JG; Quirion R
    J Comp Neurol; 1993 Jul; 333(3):375-97. PubMed ID: 8349849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy.
    Schwarzer C; Kofler N; Sperk G
    Mol Pharmacol; 1998 Jan; 53(1):6-13. PubMed ID: 9443927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.